ANTIEPILEPTIC DRUG DEVELOPMENT PROGRAM

[1] [Anonymous], ARCH EXP PATHOL PHAR

[2] CHEN G, 1951, J PHARMACOL EXP THER, V103, P54

[3] GOODMAN LS, 1953, J PHARMACOL EXP THER, V108, P168

[4] Hauptmann A., 1912, Munich Medicine. Wochenschr, V59, P1907

[5] Locock C., 1857, The Lancet, V70, P527

[6] MATTSON RH, 1983, NEUROLOGY, V33, P1

[7] A new series of anticonvulsant drugs tested by experiments on animals [J]. ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1938, 39 (05): : 1003 - 1015

[8] Sodium diphenyl hydantoinate in the treatment of convulsive disorders [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1938, 111 : 1068 - 1073

[9] Richards R.K., 1944, FED PROC, V3, P39

[10] Spiegel EA, 1937, J LAB CLIN MED, V22, P1274

[1] [Anonymous], ARCH EXP PATHOL PHAR

[2] CHEN G, 1951, J PHARMACOL EXP THER, V103, P54

[3] GOODMAN LS, 1953, J PHARMACOL EXP THER, V108, P168

[4] Hauptmann A., 1912, Munich Medicine. Wochenschr, V59, P1907

[5] Locock C., 1857, The Lancet, V70, P527

[6] MATTSON RH, 1983, NEUROLOGY, V33, P1

[7] A new series of anticonvulsant drugs tested by experiments on animals [J]. ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1938, 39 (05): : 1003 - 1015

[8] Sodium diphenyl hydantoinate in the treatment of convulsive disorders [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1938, 111 : 1068 - 1073

[9] Richards R.K., 1944, FED PROC, V3, P39

[10] Spiegel EA, 1937, J LAB CLIN MED, V22, P1274